Pattern of Buprenorphine Treatment Retention Among Youth Aged 10 to 18 Years—US, 2015 to 2021

Aug 2, 2024
1 min read

Pattern of Buprenorphine Treatment Retention Among Youth Aged 10 to 18 Years—US, 2015 to 2021, in JAMA Pediatrics

key takeaway: "Youth who initiated buprenorphine treatment in 2016 were retained in treatment longer than those who began treatment in other years. Policy changes in the Comprehensive Addiction and Recovery Act of 20166 and the COVID-19 pandemic may have impacted prescription practices and accessibility of services. Approximately 82% of youth had only 1 treatment episode."

Recent Posts

See All

Mental Health of Youths Who Use Puberty Blockers

Mental Health of Youths Who Use Puberty Blockers, in JAMA Network Open key takeaway: "prescription of a puberty blocker was associated with decreased adjusted odds of mood disorder and suicidal though

Availability of Naloxone in Retail Pharmacies Following Introduction of Over-the-Counter Status

Availability of Naloxone in Retail Pharmacies Following Introduction of Over-the-Counter Status, in JAMA Network Open key takeaway: "61.4% of pharmacies reported same-day naloxone availability without

A Decade of Innovations and Insights from FDA’s “The Real Cost” Campaigns and Youth Prevention Efforts

A Decade of Innovations and Insights from FDA’s “The Real Cost” Campaigns and Youth Prevention Efforts, special issue of American Journal of Preventive Medicine key takeaway, from the conclusion artic

PROMOTING BEHAVIORAL HEALTH TEAM

A Committee of the Partnership for a Healthier Fairfax

Pattern of Buprenorphine Treatment Retention Among Youth Aged 10 to 18 Years—US, 2015 to 2021

Recent Posts

Comments